165 related articles for article (PubMed ID: 22592612)
1. Washout of mass-like benign breast lesions at dynamic magnetic resonance imaging.
Tannaphai P; Trimboli RM; Carbonaro LA; Viganò S; Di Leo G; Sardanelli F
J Comput Assist Tomogr; 2012; 36(3):301-5. PubMed ID: 22592612
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
[TBL] [Abstract][Full Text] [Related]
3. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
[TBL] [Abstract][Full Text] [Related]
4. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.
Mussurakis S; Buckley DL; Drew PJ; Fox JN; Carleton PJ; Turnbull LW; Horsman A
Clin Radiol; 1997 Jul; 52(7):516-26. PubMed ID: 9240704
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging of breast tumors at 3 and 7 T: a comparison.
Gruber S; Pinker K; Zaric O; Minarikova L; Chmelik M; Baltzer P; Boubela RN; Helbich T; Bogner W; Trattnig S
Invest Radiol; 2014 May; 49(5):354-62. PubMed ID: 24619208
[TBL] [Abstract][Full Text] [Related]
6. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
7. Improving malignancy prediction in breast lesions with the combination of apparent diffusion coefficient and dynamic contrast-enhanced kinetic descriptors.
Nogueira L; Brandão S; Matos E; Gouveia Nunes R; Ferreira HA; Loureiro J; Ramos I
Clin Radiol; 2015 Sep; 70(9):1016-25. PubMed ID: 26135541
[TBL] [Abstract][Full Text] [Related]
8. Handling a high relaxivity contrast material for dynamic breast MR imaging using higher thresholds for the initial enhancement.
Carbonaro LA; Verardi N; Di Leo G; Sardanelli F
Invest Radiol; 2010 Mar; 45(3):114-20. PubMed ID: 20065856
[TBL] [Abstract][Full Text] [Related]
9. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
Choi N; Han BK; Choe YH; Kim HS
J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
[TBL] [Abstract][Full Text] [Related]
10. CE-Magnetic Resonance Mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer.
Pediconi F; Venditti F; Padula S; Roselli A; Moriconi E; Giacomelli L; Catalano C; Passariello R
Radiol Med; 2005; 110(1-2):61-8. PubMed ID: 16163140
[TBL] [Abstract][Full Text] [Related]
11. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
[TBL] [Abstract][Full Text] [Related]
12. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
[TBL] [Abstract][Full Text] [Related]
13. Differentiating benign and malignant breast lesions with T2*-weighted first pass perfusion imaging.
Kvistad KA; Lundgren S; Fjøsne HE; Smenes E; Smethurst HB; Haraldseth O
Acta Radiol; 1999 Jan; 40(1):45-51. PubMed ID: 9973902
[TBL] [Abstract][Full Text] [Related]
14. MR dynamic enhancement of breast lesions: high temporal resolution during the first-minute versus eight-minute study.
Sardanelli F; Rescinito G; Giordano GD; Calabrese M; Parodi RC
J Comput Assist Tomogr; 2000; 24(5):724-31. PubMed ID: 11045693
[TBL] [Abstract][Full Text] [Related]
15. Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions.
Partridge SC; Stone KM; Strigel RM; DeMartini WB; Peacock S; Lehman CD
Acad Radiol; 2014 Sep; 21(9):1195-203. PubMed ID: 24998690
[TBL] [Abstract][Full Text] [Related]
16. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
[TBL] [Abstract][Full Text] [Related]
17. Single bolus split dynamic MRI: Is the combination of high spatial and dual-echo high temporal resolution interleaved sequences useful in the differential diagnosis of breast masses?
Grøvik E; Bjørnerud A; Kurz KD; Kingsrød M; Sandhaug M; Storås TH; Gjesdal KI
J Magn Reson Imaging; 2015 Jul; 42(1):180-7. PubMed ID: 25211038
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine.
Heywang-Köbrunner SH; Haustein J; Pohl C; Beck R; Lommatzsch B; Untch M; Nathrath WB
Radiology; 1994 Jun; 191(3):639-46. PubMed ID: 8184040
[TBL] [Abstract][Full Text] [Related]
19. Intraindividual, randomized comparison of the macrocyclic contrast agents gadobutrol and gadoterate meglumine in breast magnetic resonance imaging.
Fallenberg EM; Renz DM; Karle B; Schwenke C; Ingod-Heppner B; Reles A; Engelken FJ; Huppertz A; Hamm B; Taupitz M
Eur Radiol; 2015 Mar; 25(3):837-49. PubMed ID: 25249313
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]